Legal status · United States
Is Platelet Factor 4 legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Platelet Factor 4 is not an approved medicine in the United States; its classification is "Research use only; not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, no human study is cited on its profile.
Platelet Factor 4 in the United States at a glance
| Classification | Research use only; not approved |
|---|---|
| FDA approval status | Not approved as a therapy and never administered to a human. PF4 appears in clinical medicine as the antigen measured in testing for heparin-induced thrombocytopenia, which is diagnostic rather than therapeutic. |
| Human studies cited | 0 of 4 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Platelet Factor 4 profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
No product containing Platelet Factor 4 is approved by FDA for any use in the United States, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in the United States. This page is general information, not legal advice.
What Platelet Factor 4 is
A platelet chemokine that three independent laboratories reported in 2023 restores cognition in aged mice. It is higher in young human plasma than old, and has never been given to a person.
In August 2023 three independent groups published in Nature Communications, Nature and Nature Aging within a month of each other, all converging on the same molecule. Platelet factor 4, also called CXCL4, is a chemokine released by platelets.
Mechanism: In mice, systemic PF4 reduces age-related hippocampal neuroinflammation at transcriptional and cellular levels, produces molecular changes associated with synaptic plasticity, and improves cognition, with the chemokine receptor CXCR3 mediating part of the effect and with restoration of the ageing peripheral immune system implicated. One of the 2023 papers places PF4 downstream of klotho.
Regulatory history: Not approved as a therapy and never administered to a human. PF4 appears in clinical medicine as the antigen measured in testing for heparin-induced thrombocytopenia, which is diagnostic rather than therapeutic.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Platelet Factor 4 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Platelet Factor 4 in other countries
Frequently asked questions
Is Platelet Factor 4 legal in the United States?
No. Platelet Factor 4 is not an approved medicine in the United States; its classification is "Research use only; not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, no human study is cited on its profile.
Can I buy Platelet Factor 4 in the United States?
No approved product exists to buy. In the United States Platelet Factor 4 is classified as "Research use only; not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is Platelet Factor 4 FDA approved?
No. FDA status: Not approved as a therapy and never administered to a human. PF4 appears in clinical medicine as the antigen measured in testing for heparin-induced thrombocytopenia, which is diagnostic rather than therapeutic.. Current US classification: "Research use only; not approved". On the evidence, no human study is cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Platelet Factor 4 live on its compound profile.
Platelet Factor 4 profileThis page is general information about the regulatory status of Platelet Factor 4 in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.